Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats

Neuroscience

Volumn 189, Issue , 2011, Pages 1-11

  Zhao, C Z ^a   Zhao, B ^a   Zhang, X Y ^a   Huang, X Q ^a   Shi, W Z ^a   Liu, H L ^a   Fang, S H ^a   Lu, Y B ^a   Zhang, W P ^a   Tang, F D ^a   Wei, E Q ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Astrocyte; Cysteinyl leukotriene receptor; Focal cerebral ischemia; Microglia; Neuron

Indexed keywords

CYSTEINYLLEUKOTRIENE RECEPTOR 2; LEUKOTRIENE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; GLIA; MALE; MICROGLIA; MICROGLIOSIS; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR UPREGULATION;

ANIMALS; ASTROCYTES; BRAIN; GLIOSIS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LEUKOTRIENE;

EID: 79960912798     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.066     Document Type: Article

References (46)

1. Ballerini P., Di Iorio P., Ciccarelli R., Caciagli F., Poli A., Beraudi A., Buccella S., D'Alimonte I., D'Auro M., Nargi E., Patricelli P., Visini D., Traversa U. P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia. Int J Immunopathol Pharmacol 2005, 18:255-268.
2. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
3. Beller T.C., Maekawa A., Friend D.S., Austen K.F., Kanaoka Y. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 2004, 279:46129-46134.
4. Brink C., Dahlen S.E., Drazen J., Evans J.F., Hay D.W., Nicosia S., Serhan C.N., Shimizu T., Yokomizo T. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 2003, 55:195-227.
5. Candelario-Jalil E. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 2009, 10:644-654.
6. Capra V., Thompson M.D., Sala A., Cole D.E., Folco G., Rovati G.E. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res Rev 2007, 27:469-527.
7. Chu L.S., Wei E.Q., Yu G.L., Fang S.H., Zhou Y., Wang M.L., Zhang W.P. Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice. Acta Pharmacol Sin 2006, 27:282-288.
8. Ciccarelli R., D'Alimonte I., Santavenere C., D'Auro M., Ballerini P., Nargi E., Buccella S., Nicosia S., Folco G., Caciagli F., Di Iorio P. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway. Eur J Neurosci 2004, 20:1514-1524.
9. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003, 26:248-254.
10. Fang S.H., Wei E.Q., Zhou Y., Wang M.L., Zhang W.P., Yu G.L., Chu L.S., Chen Z. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience 2006, 140:969-979.
11. Fang S.H., Zhou Y., Chu L.S., Zhang W.P., Wang M.L., Yu G.L., Peng F., Wei E.Q. Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia. Neurosci Lett 2007, 412:78-83.
12. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S., Stocco R., Bellefeuille J.N., Abramovitz M., Cheng R., Williams D.L., Zeng Z., Liu Q., Ma L., Clements M.K., Coulombe N., Liu Y., Austin C.P., George S.R., O'Neill G.P., Metters K.M., Lynch K.R., Evans J.F. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000, 275:30531-30536.
13. Huang X.J., Zhang W.P., Li C.T., Shi W.Z., Fang S.H., Lu Y.B., Chen Z., Wei E.Q. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation. Glia 2008, 56:27-37.
14. Hui Y., Cheng Y., Smalera I., Jian W., Goldhahn L., Fitzgerald G.A., Funk C.D. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 2004, 110:3360-3366.
15. Ito D., Tanaka K., Suzuki S., Dembo T., Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001, 32:1208-1215.
16. Jiang W., Hall S.R., Moos M.P., Cao R.Y., Ishii S., Ogunyankin K.O., Melo L.G., Funk C.D. Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury. Am J Pathol 2008, 172:592-602.
17. Jiang Y., Borrelli L., Bacskai B.J., Kanaoka Y., Boyce J.A. P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells. J Immunol 2009, 182:1129-1137.
18. Jiang Y., Borrelli L.A., Kanaoka Y., Bacskai B.J., Boyce J.A. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 2007, 110:3263-3270.
19. Kanaoka Y., Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 2004, 173:1503-1510.
20. Kriz J. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol 2006, 18:145-157.
21. Lo E.H. A new penumbra: transitioning from injury into repair after stroke. Nat Med 2008, 14:497-500.
22. Maekawa A., Balestrieri B., Austen K.F., Kanaoka Y. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci U S A 2009, 106:11685-11690.
23. Magnusson C., Ehrnstrom R., Olsen J., Sjolander A. An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation. Cancer Res 2007, 67:9190-9198.
24. Magnusson C., Liu J., Ehrnstrom R., Manjer J., Jirstrom K., Andersson T., Sjolander A. Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients. Int J Cancer 2011, 129:9-22.
25. Magnusson C., Mezhybovska M., Lorinc E., Fernebro E., Nilbert M., Sjolander A. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer. Eur J Cancer 2010, 46:826-835.
26. Moos M.P., Mewburn J.D., Kan F.W., Ishii S., Abe M., Sakimura K., Noguchi K., Shimizu T., Funk C.D. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport. FASEB J 2008, 22:4352-4362.
27. Moxon-Emre I., Schlichter L.C. Evolution of inflammation and white matter injury in a model of transient focal ischemia. J Neuropathol Exp Neurol 2010, 69:1-15.
28. Narantuya D., Nagai A., Sheikh A.M., Masuda J., Kobayashi S., Yamaguchi S., Kim S.U. Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS One 2010, 5:e11746.
29. Parhamifar L., Sime W., Yudina Y., Vilhardt F., Morgelin M., Sjolander A. Ligand-induced tyrosine phosphorylation of cysteinyl leukotriene receptor 1 triggers internalization and signaling in intestinal epithelial cells. PLoS One 2010, 5:e14439.
30. Paruchuri S., Tashimo H., Feng C., Maekawa A., Xing W., Jiang Y., Kanaoka Y., Conley P., Boyce J.A. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J Exp Med 2009, 206:2543-2555.
31. Qi L.L., Fang S.H., Shi W.Z., Huang X.Q., Zhang X.Y., Lu Y.B., Zhang W.P., Wei E.Q. CysLT2 receptor-mediated AQP4 up-regulation is involved in ischemic-like injury through activation of ERK and p38 MAPK in rat astrocytes. Life Sci 2011, 88:50-56.
32. Rolls A., Shechter R., Schwartz M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 2009, 10:235-241.
33. Schilling M., Besselmann M., Leonhard C., Mueller M., Ringelstein E.B., Kiefer R. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 2003, 183:25-33.
34. Sheng W.W., Li C.T., Zhang W.P., Yuan Y.M., Hu H., Fang S.H., Zhang L., Wei E.Q. Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death. Biochem Biophys Res Commun 2006, 346:19-25.
35. Singh R.K., Gupta S., Dastidar S., Ray A. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 2010, 85:336-349.
36. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35.
37. Wang M.L., Huang X.J., Fang S.H., Yuan Y.M., Zhang W.P., Lu Y.B., Ding Q., Wei E.Q. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression. Biochem Biophys Res Commun 2006, 350:399-404.
38. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J Neuroimmunol 2007, 184:53-68.
39. Woszczek G., Chen L.Y., Nagineni S., Alsaaty S., Harry A., Logun C., Pawliczak R., Shelhamer J.H. IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes. J Immunol 2007, 178:5262-5270.
40. Yano T., Anraku S., Nakayama R., Ushijima K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 2003, 98:465-473.
41. Yenari M.A., Kauppinen T.M., Swanson R.A. Microglial activation in stroke: therapeutic targets. Neurotherapeutics 2010, 7:378-391.
42. Yu G.L., Wei E.Q., Wang M.L., Zhang W.P., Zhang S.H., Weng J.Q., Chu L.S., Fang S.H., Zhou Y., Chen Z., Zhang Q., Zhang L.H. Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Res 2005, 1053:116-125.
43. Zhang L.P., Zhao C.Z., Shi W.Z., Qi L.L., Lu Y.B., Zhang Y.M., Zhang L.H., Fang S.H., Bao J.F., Shen J.G., Wei E.Q. Preparation and identification of polyclonal antibody against cysteinyl leukotriene receptor 2. Zhejiang Da Xue Xue Bao Yi Xue Ban 2009, 38:591-597.
44. Zhang W.P., Wei E.Q., Mei R.H., Zhu C.Y., Zhao M.H. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin 2002, 23:871-877.
45. Zhao R., Shi W.Z., Zhang Y.M., Fang S.H., Wei E.Q. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. J Pharm Pharmacol 2011, 63:550-557.
46. Zhou Y., Wei E.Q., Fang S.H., Chu L.S., Wang M.L., Zhang W.P., Yu G.L., Ye Y.L., Lin S.C., Chen Z. Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sci 2006, 79:1645-1656.